应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RGEN Repligen Corporation
已收盘 08-14 16:00:00 EDT
126.64
-0.51
-0.40%
盘后
126.64
+0.00
0.00%
17:39 EDT
最高
126.86
最低
124.43
成交量
68.67万
今开
125.96
昨收
127.15
日振幅
1.91%
总市值
71.24亿
流通市值
66.67亿
总股本
5,626万
成交额
8,650万
换手率
1.30%
流通股本
5,265万
市净率
3.46
ROE
-0.68%
每股收益
-0.25
52周最高
182.52
52周最低
102.97
市盈率
-512.70
股息
0.00
股息收益率
0.00
ROA
1.12%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读 | 瑞普基因季报营收超预期,股价盘中大涨9.34%
异动解读 · 07-29
异动解读 | 瑞普基因季报营收超预期,股价盘中大涨9.34%
异动解读 | 瑞普基因季报超预期,盘前大涨8.40%
异动解读 · 07-29
异动解读 | 瑞普基因季报超预期,盘前大涨8.40%
Repligen Corporation盘中异动 股价大涨5.88%
市场透视 · 07-29
Repligen Corporation盘中异动 股价大涨5.88%
Repligen Corporation盘中异动 早盘股价大跌5.09%报123.56美元
市场透视 · 07-14
Repligen Corporation盘中异动 早盘股价大跌5.09%报123.56美元
Repligen Corporation盘中异动 快速上涨5.02%
市场透视 · 07-01
Repligen Corporation盘中异动 快速上涨5.02%
Repligen获巴克莱首次覆盖,给予增持评级, 目标价150.00美元。
金融界 · 06-24
Repligen获巴克莱首次覆盖,给予增持评级, 目标价150.00美元。
Repligen Corporation盘中异动 早盘急速下挫5.32%
市场透视 · 06-16
Repligen Corporation盘中异动 早盘急速下挫5.32%
Repligen Corporation盘中异动 股价大涨5.00%报124.50美元
市场透视 · 06-03
Repligen Corporation盘中异动 股价大涨5.00%报124.50美元
Repligen Corporation盘中异动 股价大跌5.03%
市场透视 · 05-21
Repligen Corporation盘中异动 股价大跌5.03%
Repligen Corporation盘中异动 股价大跌5.01%报133.86美元
市场透视 · 05-06
Repligen Corporation盘中异动 股价大跌5.01%报133.86美元
Repligen Corporation2025财年第一财季实现净利润5.83百万美元,同比增加76.67%
市场透视 · 05-03
Repligen Corporation2025财年第一财季实现净利润5.83百万美元,同比增加76.67%
Repligen Corporation盘中异动 快速跳水5.90%报135.15美元
市场透视 · 04-29
Repligen Corporation盘中异动 快速跳水5.90%报135.15美元
Repligen Corporation盘中异动 股价大涨5.57%
市场透视 · 04-22
Repligen Corporation盘中异动 股价大涨5.57%
加拿大投资银行集团:维持Repligen评级,由持有调整至持有评级, 目标价由170.00美元调整至150.00美元。
金融界 · 04-16
加拿大投资银行集团:维持Repligen评级,由持有调整至持有评级, 目标价由170.00美元调整至150.00美元。
Repligen Corporation盘中异动 急速上涨5.15%报121.12美元
市场透视 · 04-11
Repligen Corporation盘中异动 急速上涨5.15%报121.12美元
Repligen Corporation盘中异动 快速下跌5.17%报147.65美元
市场透视 · 03-10
Repligen Corporation盘中异动 快速下跌5.17%报147.65美元
Repligen Corporation盘中异动 股价大跌5.16%报147.37美元
市场透视 · 03-04
Repligen Corporation盘中异动 股价大跌5.16%报147.37美元
Repligen Corporation盘中异动 下午盘股价大涨5.01%
市场透视 · 02-24
Repligen Corporation盘中异动 下午盘股价大涨5.01%
小摩:维持Repligen(RGEN.US)评级,由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。
金融界 · 02-21
小摩:维持Repligen(RGEN.US)评级,由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。
加拿大投资银行集团:维持Repligen(RGEN.US)评级,由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。
金融界 · 02-21
加拿大投资银行集团:维持Repligen(RGEN.US)评级,由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。
加载更多
公司概况
公司名称:
Repligen Corporation
所属市场:
NASDAQ
上市日期:
--
主营业务:
Repligen Corporation是供应生物制药关键产品的领军者。公司生产的蛋白质A为重要生命科学研究公司提供长期供应、长期合约,并同时直接向制药加工链终端使用者销售。公司向SecreFlo公司最新的药物提供专业生物研发产品,这种药物已经向美国食品药品行政管理局递交申请并已获得优先检验,公司已向欧洲药物管理机构递交了市场授权许可。SecreFlo是研发诊断胰腺炎和多种潜在胰腺疾病的合成人类激素药物新型显像剂的企业。公司进行两个早期中枢神经系统罕见疾病项目研究,弗里德里希运动失调和脊柱肌肉萎缩进入到了临床试验的第一阶段。此外,公司已从Bristol-Myers Squibb公司获得知识产权的额外许可——该公司可在美国对药物阿巴西普实价销售的专利权。公司于1981年5月成立。
发行价格:
--
{"stockData":{"symbol":"RGEN","market":"US","secType":"STK","nameCN":"Repligen Corporation","latestPrice":126.64,"timestamp":1755201600000,"preClose":127.15,"halted":0,"volume":686685,"hourTrading":{"tag":"盘后","latestPrice":126.64,"preClose":126.64,"latestTime":"17:39 EDT","volume":16933,"amount":2144391.96,"timestamp":1755207540078},"delay":0,"floatShares":52647009,"shares":56257618,"eps":-0.247008,"marketStatus":"已收盘","change":-0.51,"latestTime":"08-14 16:00:00 EDT","open":125.96,"high":126.86,"low":124.43,"amount":86499724.93035,"amplitude":0.019111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.247008,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1755244800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":127.15,"preHourTrading":{"tag":"盘前","latestPrice":124.6,"preClose":127.15,"latestTime":"09:22 EDT","volume":214,"amount":27204.37978,"timestamp":1755177771605},"postHourTrading":{"tag":"盘后","latestPrice":126.64,"preClose":126.64,"latestTime":"17:39 EDT","volume":16933,"amount":2144391.96,"timestamp":1755207540078},"volumeRatio":0.885139,"impliedVol":0.379,"impliedVolPercentile":0.008},"requestUrl":"/m/hq/s/RGEN","defaultTab":"news","newsList":[{"id":"1148168475","title":"异动解读 | 瑞普基因季报营收超预期,股价盘中大涨9.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148168475","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148168475?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:54","pubTimestamp":1753797298,"startTime":"0","endTime":"0","summary":"周二盘中,生物制药公司瑞普基因股价大涨9.34%,主要受益于公司公布的第二季度财报中营收数据优于市场预期。根据瑞普基因发布的财报显示,截至6月30日的第二季度,公司营收同比增长18.4%,达到1.8237亿美元,超过分析师预期的1.7502亿美元。尽管瑞普基因今年迄今股价累计下跌16.9%,但分析师对公司前景仍持乐观态度。这些积极因素可能进一步推动了投资者的买入热情,导致股价在财报发布后出现显著上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RGEN"],"gpt_icon":0},{"id":"1152262236","title":"异动解读 | 瑞普基因季报超预期,盘前大涨8.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152262236","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152262236?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:40","pubTimestamp":1753796416,"startTime":"0","endTime":"0","summary":"7月29日周二,生物制药公司瑞普基因盘前股价大涨8.40%,主要受益于公司公布的第二季度财报优于市场预期。根据瑞普基因发布的财报显示,截至6月30日的第二季度,公司调整后每股收益为0.37美元,虽略低于分析师平均预期的0.39美元,但高于去年同期的0.33美元。尽管公司股价在本季度下跌了3.8%,今年迄今为止累计下跌16.9%,但分析师对瑞普基因的前景仍持乐观态度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RGEN"],"gpt_icon":0},{"id":"2555054467","title":"Repligen Corporation盘中异动 股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555054467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555054467?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:32","pubTimestamp":1753795927,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时32分,Repligen Corporation股票出现波动,股价快速上涨5.88%。Repligen Corporation股票所在的医疗设备行业中,整体涨幅为0.35%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗、细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213207a6c7f498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213207a6c7f498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","RGEN","BK4121","LU0757428866.USD"],"gpt_icon":0},{"id":"2551187422","title":"Repligen Corporation盘中异动 早盘股价大跌5.09%报123.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551187422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551187422?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:41","pubTimestamp":1752500467,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时41分,Repligen Corporation股票出现异动,股价快速跳水5.09%。截至发稿,该股报123.56美元/股,成交量7.0172万股,换手率0.12%,振幅3.60%。Repligen Corporation股票所在的医疗设备行业中,整体跌幅为0.18%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗、细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214107a6a8f428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214107a6a8f428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","RGEN","BK4121","LU0757428866.USD"],"gpt_icon":0},{"id":"2548883719","title":"Repligen Corporation盘中异动 快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548883719?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:51","pubTimestamp":1751385073,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时51分,Repligen Corporation股票出现异动,股价大幅上涨5.02%。Repligen Corporation股票所在的医疗设备行业中,整体跌幅为0.48%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗、细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070123511497961620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070123511497961620&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0757428866.USD","RGEN","LU1815336091.USD","BK4121"],"gpt_icon":0},{"id":"2545238089","title":"Repligen获巴克莱首次覆盖,给予增持评级, 目标价150.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2545238089","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545238089?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:24","pubTimestamp":1750771483,"startTime":"0","endTime":"0","summary":"Repligen(RGEN.US)获巴克莱首次覆盖,给予增持评级, 目标价150.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624212755978ce78c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624212755978ce78c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN"],"gpt_icon":0},{"id":"2543160332","title":"Repligen Corporation盘中异动 早盘急速下挫5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543160332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543160332?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:35","pubTimestamp":1750080913,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时35分,Repligen Corporation股票出现异动,股价快速下挫5.32%。截至发稿,该股报120.74美元/股,成交量3.419万股,换手率0.06%,振幅3.90%。Repligen Corporation股票所在的医疗设备行业中,整体涨幅为0.45%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162135139781ed0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162135139781ed0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0757428866.USD","LU1815336091.USD","RGEN","BK4121"],"gpt_icon":0},{"id":"2540870613","title":"Repligen Corporation盘中异动 股价大涨5.00%报124.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540870613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540870613?lang=zh_cn&edition=full","pubTime":"2025-06-04 00:54","pubTimestamp":1748969688,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日00时54分,Repligen Corporation股票出现波动,股价快速上涨5.00%。截至发稿,该股报124.50美元/股,成交量35.5296万股,换手率0.63%,振幅7.74%。Repligen Corporation股票所在的医疗设备行业中,整体跌幅为0.69%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604005448950d2fec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604005448950d2fec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","BK4121","LU1815336091.USD","LU0757428866.USD"],"gpt_icon":0},{"id":"2537803956","title":"Repligen Corporation盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537803956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537803956?lang=zh_cn&edition=full","pubTime":"2025-05-22 03:22","pubTimestamp":1747855338,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日03时22分,Repligen Corporation股票出现异动,股价大幅跳水5.03%。截至发稿,该股报121.17美元/股,成交量28.729万股,换手率0.51%,振幅3.82%。Repligen Corporation股票所在的医疗设备行业中,整体跌幅为1.46%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052203221894fe3f76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052203221894fe3f76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","LU1815336091.USD","BK4121","LU0757428866.USD"],"gpt_icon":0},{"id":"2533001650","title":"Repligen Corporation盘中异动 股价大跌5.01%报133.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533001650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533001650?lang=zh_cn&edition=full","pubTime":"2025-05-07 01:28","pubTimestamp":1746552499,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日01时28分,Repligen Corporation股票出现波动,股价快速下跌5.01%。截至发稿,该股报133.86美元/股,成交量34.6935万股,换手率0.62%,振幅5.66%。Repligen Corporation股票所在的医疗设备行业中,整体跌幅为0.93%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507012819a6d549bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507012819a6d549bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","BK4121","RGEN","LU0757428866.USD"],"gpt_icon":0},{"id":"2532559613","title":"Repligen Corporation2025财年第一财季实现净利润5.83百万美元,同比增加76.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532559613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532559613?lang=zh_cn&edition=full","pubTime":"2025-05-04 00:00","pubTimestamp":1746288057,"startTime":"0","endTime":"0","summary":"5月4日,Repligen Corporation公布财报,公告显示公司2025财年第一财季净利润为5.83百万美元,同比增加76.67%;其中营业收入为1.69亿美元,同比增加10.46%,每股基本收益为0.10美元。从资产负债表来看,Repligen Corporation总负债8.67亿美元,其中短期债务15.15百万美元,资产负债比为3.29,流动比率为6.79。机构评级:截至2025年5月4日,当前有16家机构对Repligen Corporation目标价做出预测,其中目标均价为184.00美元,其中最低目标价为140.00美元,最高目标价为220.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250504000137a4711185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250504000137a4711185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN"],"gpt_icon":0},{"id":"2531378067","title":"Repligen Corporation盘中异动 快速跳水5.90%报135.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531378067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531378067?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:30","pubTimestamp":1745933427,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时30分,Repligen Corporation股票出现异动,股价快速下挫5.90%。截至发稿,该股报135.15美元/股,成交量1.1675万股,换手率0.02%,振幅0.00%。Repligen Corporation股票所在的医疗设备行业中,整体涨幅为0.00%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213027974a38d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213027974a38d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0757428866.USD","RGEN","LU1815336091.USD","BK4121"],"gpt_icon":0},{"id":"2529586773","title":"Repligen Corporation盘中异动 股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529586773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529586773?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:30","pubTimestamp":1745328654,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时30分,Repligen Corporation股票出现波动,股价快速上涨5.57%。Repligen Corporation股票所在的医疗设备行业中,整体涨幅为0.00%。其相关个股中,Repligen Corporation、Glucotrack, Inc.、中进医疗涨幅较大,Sharps Technology Inc.、Glucotrack, Inc.、Microbot Medical Inc.较为活跃,换手率分别为89.06%、0.97%、0.32%,振幅较大的相关个股有AtriCure、Biolife Solutions, Inc.、Merit Medical Systems, Inc.,振幅分别为1.80%、1.56%、1.47%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222130559740b8ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222130559740b8ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","RGEN","LU0757428866.USD","BK4121"],"gpt_icon":0},{"id":"2528403278","title":"加拿大投资银行集团:维持Repligen评级,由持有调整至持有评级, 目标价由170.00美元调整至150.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528403278","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528403278?lang=zh_cn&edition=full","pubTime":"2025-04-17 01:34","pubTimestamp":1744824850,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:维持Repligen(RGEN.US)评级,由持有调整至持有评级, 目标价由170.00美元调整至150.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417013656973a2ebc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417013656973a2ebc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN"],"gpt_icon":0},{"id":"2526613720","title":"Repligen Corporation盘中异动 急速上涨5.15%报121.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526613720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526613720?lang=zh_cn&edition=full","pubTime":"2025-04-12 00:57","pubTimestamp":1744390650,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日00时57分,Repligen Corporation股票出现异动,股价急速拉升5.15%。截至发稿,该股报121.12美元/股,成交量41.7871万股,换手率0.74%,振幅8.50%。Repligen Corporation股票所在的医疗设备行业中,整体涨幅为0.38%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412005731aa2c6cfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412005731aa2c6cfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","RGEN","LU0757428866.USD","BK4121"],"gpt_icon":0},{"id":"2518827601","title":"Repligen Corporation盘中异动 快速下跌5.17%报147.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518827601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518827601?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:52","pubTimestamp":1741614761,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时52分,Repligen Corporation股票出现异动,股价急速跳水5.17%。截至发稿,该股报147.65美元/股,成交量7.3314万股,换手率0.13%,振幅2.90%。Repligen Corporation股票所在的医疗设备行业中,整体跌幅为1.40%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215241abf30469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215241abf30469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","LU1815336091.USD","BK4121","LU0757428866.USD"],"gpt_icon":0},{"id":"2517605707","title":"Repligen Corporation盘中异动 股价大跌5.16%报147.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517605707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517605707?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:47","pubTimestamp":1741103262,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时47分,Repligen Corporation股票出现波动,股价大幅下跌5.16%。截至发稿,该股报147.37美元/股,成交量11.4499万股,换手率0.20%,振幅4.70%。Repligen Corporation股票所在的医疗设备行业中,整体跌幅为1.24%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234742a25f19d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234742a25f19d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","RGEN","LU0757428866.USD","BK4121"],"gpt_icon":0},{"id":"2514703863","title":"Repligen Corporation盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703863?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:06","pubTimestamp":1740427594,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时06分,Repligen Corporation股票出现波动,股价快速拉升5.01%。截至发稿,该股报166.96美元/股,成交量47.4486万股,换手率0.85%,振幅5.20%。Repligen Corporation股票所在的医疗设备行业中,整体涨幅为0.23%。Repligen Corporation公司简介:Repligen 总部位于马萨诸塞州沃尔瑟姆,是一家全球生命科学公司,开发和销售用于制造生物药物的生物加工设备和用品,包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502250406349891370c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502250406349891370c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","BK4121","LU0757428866.USD","RGEN"],"gpt_icon":0},{"id":"2513097291","title":"小摩:维持Repligen(RGEN.US)评级,由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513097291","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513097291?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:22","pubTimestamp":1740151334,"startTime":"0","endTime":"0","summary":"小摩:维持Repligen(RGEN.US)评级,由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21232248320493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RGEN"],"gpt_icon":0},{"id":"2513262262","title":"加拿大投资银行集团:维持Repligen(RGEN.US)评级,由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513262262","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513262262?lang=zh_cn&edition=full","pubTime":"2025-02-21 20:40","pubTimestamp":1740141632,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:维持Repligen(RGEN.US)评级,由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21204048318756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RGEN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.repligen.com","stockEarnings":[{"period":"1week","weight":0.1343},{"period":"1month","weight":0.048},{"period":"3month","weight":0.0316},{"period":"6month","weight":-0.1346},{"period":"1year","weight":-0.2272},{"period":"ytd","weight":-0.1166}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0321},{"period":"3month","weight":0.0922},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.1897},{"period":"ytd","weight":0.1003}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Repligen Corporation是供应生物制药关键产品的领军者。公司生产的蛋白质A为重要生命科学研究公司提供长期供应、长期合约,并同时直接向制药加工链终端使用者销售。公司向SecreFlo公司最新的药物提供专业生物研发产品,这种药物已经向美国食品药品行政管理局递交申请并已获得优先检验,公司已向欧洲药物管理机构递交了市场授权许可。SecreFlo是研发诊断胰腺炎和多种潜在胰腺疾病的合成人类激素药物新型显像剂的企业。公司进行两个早期中枢神经系统罕见疾病项目研究,弗里德里希运动失调和脊柱肌肉萎缩进入到了临床试验的第一阶段。此外,公司已从Bristol-Myers Squibb公司获得知识产权的额外许可——该公司可在美国对药物阿巴西普实价销售的专利权。公司于1981年5月成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.692308,"avgChangeRate":0.096098},{"month":2,"riseRate":0.410256,"avgChangeRate":0.029809},{"month":3,"riseRate":0.538462,"avgChangeRate":0.034504},{"month":4,"riseRate":0.487179,"avgChangeRate":-0.003291},{"month":5,"riseRate":0.55,"avgChangeRate":0.045851},{"month":6,"riseRate":0.475,"avgChangeRate":-0.011153},{"month":7,"riseRate":0.5,"avgChangeRate":0.029297},{"month":8,"riseRate":0.575,"avgChangeRate":0.030983},{"month":9,"riseRate":0.358974,"avgChangeRate":-0.039812},{"month":10,"riseRate":0.461538,"avgChangeRate":0.023419},{"month":11,"riseRate":0.461538,"avgChangeRate":0.029998},{"month":12,"riseRate":0.487179,"avgChangeRate":-0.002741}],"exchange":"NASDAQ","name":"Repligen Corporation","nameEN":"Repligen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.8","shortVersion":"4.34.8","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Repligen Corporation,RGEN,Repligen Corporation股票,Repligen Corporation股票老虎,Repligen Corporation股票老虎国际,Repligen Corporation行情,Repligen Corporation股票行情,Repligen Corporation股价,Repligen Corporation股市,Repligen Corporation股票价格,Repligen Corporation股票交易,Repligen Corporation股票购买,Repligen Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}